Government Contracts Legal Forum

Rob Sneckenberg

Rob Sneckenberg

Rob Sneckenberg is an associate in Crowell & Moring’s Washington, D.C. office, where he practices in the Government Contracts group. He represents government contractors and other companies in both litigation and counseling matters, including litigating bid protests before the Government Accountability Office and Court of Federal Claims (COFC), pursuing contract claims before the Boards of Contract Appeals and COFC, and conducting ethics and compliance reviews and civil and criminal fraud investigations under the False Claims Act. Rob received his J.D. from The George Washington University Law School.



Read Rob's bio on Crowell & Moring's website

Subscribe to all posts by Rob Sneckenberg

Hiring a Former Government Official? Obtain and Hold On to the Ethics Letter

Posted in Employment, Ethics & Compliance
The Department of Defense (DoD) Office of Inspector General (IG) recently released a July 6, 2015 Memorandum announcing that it will “immediately” begin the field work for its assessment of DoD compliance with Section 847 of the 2008 National Defense Authorization Act (NDAA), “Requirements for Senior Defense Officials Seeking Employment with Defense Contractors.” Section 847… Continue Reading

Federal Circuit Requires Government to Indemnify Contractors for CERCLA Remediation Costs Based on “Taxes” Provision in WWII Contracts

Posted in Legal Developments
Last month, the Federal Circuit decided a case over 70 years in the making.  Following the bombing of Pearl Harbor in 1941 and full-scale U.S. entrance into World War II, the government entered into a series of contracts with oil companies to ramp up production of aviation gasoline (“avgas”) desperately needed for the war effort. … Continue Reading

Negotiating False Claims Act Settlements

Posted in False Claims
A prominent FCA practitioner observed twenty years ago that while FCA settlements were common, it was impossible to find a standard settlement agreement, if there was such a thing, or a DOJ policy on point.¹ His words ring true today. While the FCA has become the Government’s principal anti-fraud weapon, little has been written about the… Continue Reading

GAO Releases Protest Statistics for FY 2013

Posted in Bid Protest
In its annual report to Congress under the Competition in Contracting Act of 1984, 31 U.S.C. § 3554(e)(2), GAO disclosed the following bid protest statistics for FYs 2009-2013: For the first time since FY 2006, the number of cases filed in FY 2013 decreased from the previous year (the FY 2005 – FY 2009 statistics,… Continue Reading

C&M GC Chair and Former OFPP Administrator Participates in Televised Panel on Improving Communication and Transparency Between Government and Industry

Posted in Legal Developments
This Sunday, September 22, 2013, join Angela Styles, chair of Crowell & Moring’s Government Contracts Group, as she discusses highlights from the 2013 National Contract Management Association (NCMA) World Congress Past OFPP Administrators Panel. Angela, along with NCMA Fellow Robert Burton, will appear on Government Contracting Weekly to share lessons learned and insights on how… Continue Reading

In-Sourcing Notification Requirements

Posted in In-Sourcing
On January 29th, the Office of the Assistant Secretary of Defense issued a memorandum requiring agencies to “determine and document final decisions to in-source” and requiring contracting officers to notify their affected incumbent contractors within 20 days of receipt of such in-sourcing decisions. The memorandum, titled “Private Sector Notification Requirements in Support of In-Sourcing Actions,”… Continue Reading

What will they think of next? Qui tam relator alleges False Claims Act violation for “fraud-on-the-FDA”

Posted in False Claims
A recent case from the District of Massachusetts illustrates how the False Claims Act may be stretched to cover companies that do not even submit claims to the government. In U.S. ex rel. Ge v. Takeda Pharmaceutical Co., Nos. 10-11043-FDS, 11-10343-FDS (D. Mass. Nov. 1, 2012), the relator alleged that Takeda Pharmaceuticals violated the FCA… Continue Reading